Novel Pharmacologic Targeting of Tight Junctions and Focal Adhesions in Prostate Cancer Cells

Patrick J. Hensley(University of Kentucky), Natasha Kyprianou(University of Kentucky)

PLoS ONE

January 31, 2014

10.1371/journal.pone.0086238

Cited by 35

Related Papers

Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer

|Cancer Research|2010|350

Androgen Receptor as a Driver of Therapeutic Resistance in Advanced Prostate Cancer

|International Journal of Biological Sciences|2014|110

Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis

|Endocrinology|2017|28

Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells

|Oncotarget|2017|26